Abstract | BACKGROUND: METHODS: STUDY DESIGN: community survey. STUDY POPULATION: samples randomly drawn, after stratification from the adult population of municipal records. SAMPLE SIZE: 4999 people from seven areas within six Italian regions. Tools: Questionnaire on psychotropic drug consumption, prescription; Structured Clinical Interview NP for DSM-IV modified (ANTAS); Hamilton Depression Rating Scale (HAM-D); Mood Disorder Questionnaire (MDQ); Short Form Health Survey (SF-12). SD definition: HAM-D > 10 without lifetime diagnosis of Depressive Episode (DE). RESULTS: SD point prevalence is 5.0%. The lifetime prevalence of mania and hypomania episodes in SD is 7.3%. Benzodiazepines (BDZ) consumption in SD is 24.1%, followed by ADs (19.7%). In SD, positive for MDQ and comorbidity with Panic Disorder (PD) or Generalized Anxiety Disorders (GAD) are associated with ADs use, whereas the association between a positive MDQ and ADs use, without a diagnosis of PD or GAD, is not significant. Only in people with DE the well-being (SF-12) is higher among those using first-line antidepressants compared to those not using any medication. In people with SD no significant differences were found in terms of SF-12 score according to drug use. CONCLUSIONS: This study suggests caution in prescribing ADs to people with SD. In people with concomitant anxiety disorders and SD, it should be mandatory to perform a well-designed assessment and evaluate the presence of previous manic or hypomanic symptoms prior to prescribing ADs.
|
Authors | Mauro G Carta, Leonardo Tondo, Matteo Balestrieri, Filippo Caraci, Liliana Dell'osso, Guido Di Sciascio, Carlo Faravelli, Maria Carolina Hardoy, Maria E Lecca, Maria Francesca Moro, Krishna M Bhat, Massimo Casacchia, Filippo Drago |
Journal | BMC psychiatry
(BMC Psychiatry)
Vol. 11
Pg. 164
(Oct 10 2011)
ISSN: 1471-244X [Electronic] England |
PMID | 21985128
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antidepressive Agents
- Benzodiazepines
|
Topics |
- Adolescent
- Adult
- Aged
- Antidepressive Agents
(therapeutic use)
- Anxiety Disorders
(complications, drug therapy, epidemiology)
- Benzodiazepines
(therapeutic use)
- Bipolar Disorder
(complications, epidemiology)
- Depression
(complications, diagnosis, drug therapy, epidemiology)
- Female
- Health Surveys
(statistics & numerical data)
- Humans
- Italy
(epidemiology)
- Male
- Middle Aged
- Prevalence
- Psychiatric Status Rating Scales
(statistics & numerical data)
- Residence Characteristics
(statistics & numerical data)
|